Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study

Autor: Takashima, Atsuo, García-Alfonso, Pilar, Manneh, Raimundo, Beşen, Ali Ayberk, Hong, Yong Sang, Cuyle, Pieter-Jan, Yanez, Patricio, Burge, Matthew, Yoshino, Takayuki, Kim, Tae Won, Cui, Karen, Li, Chenxiang, Jain, Rishi, Adelberg, David, Taieb, Julien
Zdroj: In European Journal of Cancer July 2024 205
Databáze: ScienceDirect
Externí odkaz: